Literature DB >> 27784253

The Effectiveness of Topical Anti-scarring Agents and a Novel Combined Process on Cutaneous Scar Management.

Qing-Qing Fang1, Chun-Ye Chen1, Min-Xia Zhang1, Chun-Lan Huang2, Xiao-Wei Wang2, Ji-Hua Xu1, Li-Hong Wu2, Li-Yun Zhang3, Wei-Qiang Tan4.   

Abstract

Cutaneous scars (particularly hypertrophic and keloid scars), not only can cause adverse cosmetic problems, but also can be associated with emotional distress such as anxiety and depression. Comparing with other surgical treatments, patients who do not opt for or cannot opt for invasion therapies are more eligible for using the topical anti-scarring agents. In this mini-review, we have researched for and collected the data between October 2005 and October 2015, in PubMed and Web of Science, and identified those agents including silicone-based products, imiquimod, corticosteroids, 5-fluorouracil, bleomycin, mitomycin, and plant extracts such as onion extract, asiaticoside, aloe vera, vitamin E, and so on. Besides, we have listed these popular products in commercial market with their useful information. We have also described the combined process according to our clinical experience. However, to establish the more effective treatment among different types of topical agents or their combined process, large, well-designed head-to-head comparisons between individual and combined preparations in relevant patient populations are urgently needed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cutaneous scar; anti-scarring agents; combined treatment; hypertrophic scar; keloid; scar management; topical therapy; wound repair

Mesh:

Substances:

Year:  2017        PMID: 27784253     DOI: 10.2174/1381612822666161025144434

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars.

Authors:  Valeria Conti; Graziamaria Corbi; Teresa Iannaccone; Bianca Corrado; Luigi Giugliano; Serena Lembo; Amelia Filippelli; Maurizio Guida
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

Review 2.  The Roles of Inflammation in Keloid and Hypertrophic Scars.

Authors:  Zheng-Cai Wang; Wan-Yi Zhao; Yangyang Cao; Yan-Qi Liu; Qihang Sun; Peng Shi; Jia-Qin Cai; Xiao Z Shen; Wei-Qiang Tan
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

3.  The compound losartan cream inhibits scar formation via TGF-β/Smad pathway.

Authors:  Wan-Yi Zhao; Li-Yun Zhang; Gui-Da Xuan; Wei-Qiang Tan; Zheng-Cai Wang; Qing-Qing Fang; Xiao-Feng Wang; Yong-Zhong Du; Bang-Hui Shi; Dong Lou
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

4.  The connexin 43 carboxyl terminal mimetic peptide αCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin.

Authors:  Jade Montgomery; William J Richardson; Spencer Marsh; J Matthew Rhett; Francis Bustos; Katherine Degen; Gautam S Ghatnekar; Christina L Grek; L Jane Jourdan; Jeffrey W Holmes; Robert G Gourdie
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.834

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.